SPY316.18+2.40 0.76%
DIA260.72+1.68 0.65%
IXIC10,492.50+148.61 1.44%

Revolution Medicines Provided R&R Update On Its Portfolio Of Novel Targeted Cancer Therapies

Benzinga · -